Consolidated Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Assets
Cash and due from banks	$ 12,881,000	$ 12,062,000
Federal funds sold	13,101,000	4,616,000
Total cash and cash equivalents	25,982,000	16,678,000
Investment securities available for sale, at fair value	132,235,000	133,853,000
Restricted stock, at cost	2,606,000	1,564,000
Loans held for sale	6,887,000	2,268,000
Loans
Outstandings		538,427,000
Allowance for credit losses		(3,370,000)
Deferred costs, net		588,000
Total loans, net		535,645,000
Loans
Outstandings	556,170,000
Allowance for credit losses	(3,256,000)
Deferred costs, net	746,000
Total loans, net	553,660,000
Premises and equipment, net	11,890,000	11,748,000
Bank owned life insurance	12,947,000	12,798,000
Accrued interest receivable	3,482,000	3,651,000
Other assets	4,966,000	5,065,000
Total Assets	754,655,000	723,270,000
Deposits
Noninterest bearing demand	249,059,000	255,236,000
Interest bearing	379,323,000	369,507,000
Total deposits	628,382,000	624,743,000
Long-term debt - trust preferred securities	8,764,000	8,764,000
Subordinated debt, net	5,700,000	5,692,000
Federal Home Loan Bank advances	45,000,000	20,000,000
Accrued interest payable	270,000	70,000
Other liabilities	2,525,000	2,890,000
Total liabilities	690,641,000	662,159,000
Shareholders' equity
Common stock, $4 par value, 10,000,000 shares authorized; 1,485,813 shares issued and outstanding at June 30, 2023 and 1,482,790 shares issued and outstanding at December 31, 2022	5,883,000	5,868,000
Additional paid-in capital	55,420,000	55,167,000
Retained earnings	13,142,000	10,957,000
Stock in directors rabbi trust	(467,000)	(689,000)
Directors deferred fees obligation	467,000	689,000
Accumulated other comprehensive loss	(10,431,000)	(10,881,000)
Total shareholders' equity	64,014,000	61,111,000
Total liabilities and shareholders' equity	$ 754,655,000	$ 723,270,000